These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22492829)

  • 1. Prospective study on clinical effects of renal replacement therapy in treatment-resistant congestive heart failure.
    Cnossen TT; Kooman JP; Krepel HP; Konings CJ; Uszko-Lencer NH; Leunissen KM; van der Sande FM
    Nephrol Dial Transplant; 2012 Jul; 27(7):2794-9. PubMed ID: 22492829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis.
    Koch M; Kohnle M; Trapp R; Haastert B; Rump LC; Aker S
    Nephrol Dial Transplant; 2012 Jan; 27(1):375-80. PubMed ID: 21622993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure.
    Sánchez JE; Ortega T; Rodríguez C; Díaz-Molina B; Martín M; Garcia-Cueto C; Vidau P; Gago E; Ortega F
    Nephrol Dial Transplant; 2010 Feb; 25(2):605-10. PubMed ID: 19783594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis.
    Nakayama M; Nakano H; Nakayama M
    J Cardiol; 2010 Jan; 55(1):49-54. PubMed ID: 20122548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation.
    Gotloib L; Fudin R; Yakubovich M; Vienken J
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii32-6. PubMed ID: 16024831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal ultrafiltration and refractory congestive heart failure.
    Ryckelynck JP; Lobbedez T; Valette B; Le Goff C; Mazouz O; Levaltier B; Potier JC; Hurault de Ligny B
    Adv Perit Dial; 1997; 13():93-7. PubMed ID: 9360658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal dialysis in patients with refractory congestive heart failure: potential prognostic factors.
    Kunin M; Arad M; Dinour D; Freimark D; Holtzman EJ
    Blood Purif; 2013; 35(4):285-94. PubMed ID: 23712042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term effects and mortality of biventricular pacing therapy in patients with congestive heart failure].
    Wang DM; Han YL; Zang HY; Zhou WW; Jing QM; Wang ZL; Wang SL; Li F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Aug; 33(8):717-9. PubMed ID: 16188059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrafiltration for the treatment of diuretic-resistant, recurrent, acute decompensated heart failure: experience in a single center.
    De Maria E; Pignatti F; Patrizi G; Benenati PM; Ricci S; Cappelli S
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):599-604. PubMed ID: 20442667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease.
    Koch M; Haastert B; Kohnle M; Rump LC; Kelm M; Trapp R; Aker S
    Eur J Heart Fail; 2012 May; 14(5):530-9. PubMed ID: 22447950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biventricular stimulation therapy in patients with heart failure and tachycardic arrhythmias. Indications--results--prospects].
    Trappe HJ
    Biomed Tech (Berl); 2002 Oct; 47(9-10):243-9. PubMed ID: 12369212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is rapid initiation of peritoneal dialysis feasible in unplanned dialysis patients? A single-centre experience.
    Lobbedez T; Lecouf A; Ficheux M; Henri P; Hurault de Ligny B; Ryckelynck JP
    Nephrol Dial Transplant; 2008 Oct; 23(10):3290-4. PubMed ID: 18424817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved health-related quality of life and functional status after surgical ventricular restoration.
    Sartipy U; Albåge A; Lindblom D
    Ann Thorac Surg; 2007 Apr; 83(4):1381-7. PubMed ID: 17383343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End-stage heart failure: is there a role for the Batista procedure?
    Frota Filho JD; Pereira WM; Leães PE; Blacher C; Jung LA; Lucchese F
    Heart Surg Forum; 1998; 1(1):41-8. PubMed ID: 11276439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of muscular and ventricular function in dynamic cardiomyoplasty: a ten-year follow-up.
    Chachques JC; Berrebi A; Hernigou A; Cohen-Solal A; Lavergne T; Marino JP; D'Attellis N; Bensasson D; Carpentier A
    J Heart Lung Transplant; 1997 Aug; 16(8):854-68. PubMed ID: 9286778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure.
    Núñez J; González M; Miñana G; Garcia-Ramón R; Sanchis J; Bodí V; Núñez E; Puchades MJ; Palau P; Merlos P; Llàcer A; Miguel A
    Eur J Heart Fail; 2012 May; 14(5):540-8. PubMed ID: 22327061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes.
    Comín-Colet J; Ruiz S; Cladellas M; Rizzo M; Torres A; Bruguera J
    J Card Fail; 2009 Nov; 15(9):727-35. PubMed ID: 19879457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
    Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.